Junyi Wang

Jul 5, 2024 | onlinelibrary.wiley.com | Junyi Wang |Ameet Sarpatwari |Aaron S. Kesselheim |William B. Feldman

CONFLICT OF INTEREST STATEMENT William B. Feldman reports serving as a consultant for Alosa Health and as an expert witness in litigation against inhaler manufacturers. Supporting Information Filename Description pbc31158-sup-0001-SuppMat.docx34.9 KB Supporting Information REFERENCES 1 Medicare Payment Advisory Commission. Report to Congress: overview of the 340B Drug Pricing Program. MEdpAC; May 2015. Accessed September 20, 2023.

Mar 28, 2024 | nature.com | Junyi Wang |Guoping Li

AbstractThis comprehensive review explores the intricate mechanisms of PANoptosis and its implications in cancer. PANoptosis, a convergence of apoptosis, pyroptosis, and necroptosis, plays a crucial role in cell death and immune response regulation. The study delves into the molecular pathways of each cell death mechanism and their crosstalk within PANoptosis, emphasizing the shared components like caspases and the PANoptosome complex.

Feb 11, 2024 | mdpi.com | Junyi Li |Jian Yang |Yun Xia |Junyi Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Nov 28, 2023 | springerprofessional.de | Junyi Wang |Jun Fu

2024 | Buch This monograph studies the synchronization control of Markovian complex neural networks with time-varying delays, and the structure of the book is summarized as follows. Chapter 1 introduces the system description and some background knowledges, and also addresses the motivations of this monograph.

Nov 22, 2023 | jamanetwork.com | Ryan P. Knox |Junyi Wang |William B. Feldman |Aaron S. Kesselheim

Key PointsQuestion  How has the 340B Drug Pricing Program affected the US health care system? Findings  This scoping review found evidence that the 340B program was associated with revenue to hospitals, clinics, and pharmacies; expanded services for patients; and costs to pharmaceutical manufacturers. The study found mixed evidence that 340B revenue funded health care specifically for low-income populations.